Reliability of CA15-3 Tumor Marker in Monitoring Therapeutic Response in Different Molecular Subtypes of Metastatic Breast Cancer

Reliability of CA15-3 Tumor Marker in Monitoring Therapeutic Response in Different Molecular Subtypes of Metastatic Breast Cancer

Background: The prognostic impact of CA15-3 level in different molecular subtypes of metastatic breast cancer is not well elucidated yet; therefore, we conducted the present study to determine the reliability of CA15-3 tumor marker in terms of monitoring therapeutic response in different molecular s...

Full description

Bibliographic Details
Main Authors:	Alya Al Zobair, Mohammed Hayawi, Barrak Al Obeidy
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2022-07-01
Series:	Middle East Journal of Cancer
Subjects:	breast neoplasms subtypes tumor marker ca15-3
Online Access:	https://mejc.sums.ac.ir/article_48073_d04ab7ea2f832524379254962885fcd0.pdf

Similar Items

The level of serum Tumor Marker CA15-3 in women with Breast Cancer
by: Huda Hameed Othman, et al.
Published: (2018-10-01)

The level of serum Tumor Marker CA15-3 in women with Breast Cancer
by: Huda Hameed Othman, et al.
Published: (2018-10-01)

Determination of Cancer Antigen CA15-3 and Carcino Embryonic Antigen CEA concentration as Tumor Markers in Patients with Stomach and Colorectal cancers.
by: Rana. K. AL-saady, et al.
Published: (2012-10-01)

A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
by: Mutsumi Fujimoto, et al.
Published: (2023-12-01)

Clinical Evaluation of the Levels of CEA,CA15-3 and AlphaFeto Protein in Malignant and Benign Pleural Effusion
by: Zina Anwer Salloum Marrow, et al.
Published: (2008-12-01)

Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
by: Antonin Ginguay, et al.
Published: (2022-12-01)

The changes of subtype markers between first and second primary breast cancers
by: Chenyang Li, et al.
Published: (2023-06-01)

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
by: Iosè Di Stefano, et al.
Published: (2023-09-01)

Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of  Small Cell Lung Cancer
by: Yang WU, et al.
Published: (2023-04-01)

Tumor Markers in Dogs with Mammary Gland Tumors
by: Valencakova Alexandra, et al.
Published: (2023-12-01)

Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms
by: Lars Schröder, et al.
Published: (2023-09-01)

Tumor biomarkers CEA, CA19.9, CA15.3 and AFP levels in the serum of patients with COVID-19
by: Abubaker H. Ali, et al.
Published: (2022-04-01)

Sensitivity and Specificity of CA 15-3 in Detection of Breast Cancer Recurrence
by: Sh. Omidvari, et al.
Published: (2005-07-01)

Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
by: Amir Bahrami-Ahmadi, et al.
Published: (2012-01-01)

Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results
by: Janneta R. Tcherkassova, et al.
Published: (2023-06-01)

Correlation between CA-15-3 and Bone Scan findings in patients with Carcinoma Breast
by: Julekha Khatun, et al.
Published: (2022-05-01)

The value of serological markers (CA19-9 & CCSA4) in the screening and prognosis of colon cancer
by: Athraa A. M AL-Obaidy, et al.
Published: (2017-04-01)

Differences in Ca 15-3 and Homocysteine Levels in Patients with Benign Tumor and Breast Cancer
by: Mathink Toonov ANUGERAWATI, et al.
Published: (2024-03-01)

Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
by: Gennaro Nappo, et al.
Published: (2023-07-01)

Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer
by: Grażyna E. Będkowska, et al.
Published: (2021-11-01)

Guidelines for the use of tumor markers in breast cancer
by: Ignjatović Svetlana
Published: (2007-01-01)

Utility of tumor marker HE4 and CA125 to predict staging in endometrioid adenocarcinoma of the uterus
by: Narges Zamani, et al.
Published: (2015-11-01)

Carbon Nanopowder-Based Stochastic Sensor for Ultrasensitive Assay of CA 15-3, CEA and HER2 in Whole Blood
by: Raluca-Ioana Stefan-van Staden, et al.
Published: (2022-09-01)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
by: Xinjian Yu, et al.
Published: (2022-05-01)

Assessment of CA-125 First-Trimester Values as a Potential Screening Marker for Pre-Eclampsia
by: Oana Balint, et al.
Published: (2023-05-01)

Dyslipidemia and CA15-3 serum level in Iraqi Women with Breast Tumor: A Comparative Study
by: Aseel N. Kamil, et al.
Published: (2018-12-01)

Comparative study of CA19-9 levels as tumor marker in sera and tissues of patients with stomach, colon and rectum cancers
by: Amar H. Al-dujaili, et al.
Published: (2009-07-01)

Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
by: Mahgoub Samir S, et al.
Published: (2011-07-01)

Determination of carcinoembryonic antigen and cancer antigen values with the radioimmunoassay method in healthy females dogs
by: V. Ledecky, et al.
Published: (2013-05-01)

Comparative Analysis of Ki-67 in Different Scoring Patterns and its Association with other Prognostic Markers of Breast Carcinoma
by: Archana Buch, et al.
Published: (2022-05-01)

Elevation of cancer antigen 15-3 owing to oncocytic renal neoplasm in a patient without evidence of breast cancer recurrence on follow-up: a case report
by: Samuel G. Cockey, et al.
Published: (2023-12-01)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
by: Masafumi Koshiyama, et al.
Published: (2017-03-01)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
by: Aneta Cymbaluk-Płoska, et al.
Published: (2021-03-01)

Disposable Voltammetric Immunosensor for Determination and Quantification of Biomarker CA 15-3 in Biological Specimens
by: Ana Elisa F. Oliveira, et al.
Published: (2024-02-01)

Tumor marker CA-125 in adnexal inflammatory tumors
by: Nikolić Branka, et al.
Published: (2006-01-01)

Longitudinal Growth Differentiation Factor 15 (GDF15) and Long-term Intraocular Pressure Fluctuation in Glaucoma: A Pilot Study
by: Jonathan B. Lin, et al.
Published: (2021-01-01)

A Monte Carlo Machine Design to Obtain CSMA/CA Parameter Values for Unslotted IEEE 802.15.4 Based Networks
by: Selçuk ÖKDEM
Published: (2017-06-01)

GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer
by: Dan Zhao, et al.
Published: (2018-03-01)

Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast Cancer
by: Praopim Limsakul, et al.
Published: (2024-01-01)

Assessment of Interleukin-15 (IL-15) Concentration in Children with Idiopathic Nephrotic Syndrome
by: Andrzej Badeński, et al.
Published: (2023-04-01)